→
Elevance Health Inc (ELV) has a market cap of $85.28B and is currently priced at $392.68, down 1.02% from the previous close. While the company shows positive revenue growth of 9.44% year-over-year, its EPS growth is down by 8.29%, indicating potential profitability issues. The analyst consensus is moderate with 6 Strong Buy and 10 Buy ratings, suggesting a mixed view on future performance.
Hold your position in Elevance Health as the stock shows potential but also significant risks.
If Elevance can reverse its EPS decline, the 9.44% revenue growth could lead to a significant increase in profitability. Furthermore, the relatively low P/E ratio of 16.26 compared to the industry could attract more investors, boosting the stock price towards its 52-week high of $412.96.
The declining EPS growth of 8.29% poses risks to long-term profitability, and with a current ratio of 0.23, liquidity concerns may hinder operational flexibility. If the stock continues to underperform, it could drop closer to its 52-week low of $273.71.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates ELV as Neutral. Hold your position in Elevance Health as the stock shows potential but also significant risks.
The declining EPS growth of 8.29% poses risks to long-term profitability, and with a current ratio of 0.23, liquidity concerns may hinder operational flexibility. If the stock continues to underperform, it could drop closer to its 52-week low of $273.71.
If Elevance can reverse its EPS decline, the 9.44% revenue growth could lead to a significant increase in profitability. Furthermore, the relatively low P/E ratio of 16.26 compared to the industry could attract more investors, boosting the stock price towards its 52-week high of $412.96.
Elevance Health Inc (ELV) has a market cap of $85.28B and is currently priced at $392.68, down 1.02% from the previous close. While the company shows positive revenue growth of 9.44% year-over-year, its EPS growth is down by 8.29%, indicating potential profitability issues. The analyst consensus is moderate with 6 Strong Buy and 10 Buy ratings, suggesting a mixed view on future performance.
Elevance Health Inc (ELV) has a market cap of $85.28B and is currently priced at $392.68, down 1.02% from the previous close. While the company shows positive revenue growth of 9.44% year-over-year, its EPS growth is down by 8.29%, indicating potential profitability issues. The analyst consensus is moderate with 6 Strong Buy and 10 Buy ratings, suggesting a mixed view on future performance. Our overall verdict is Neutral.
Helm Terminal offers free AI-powered stock analysis for ELV at helmterminal.dev/analyze/ELV, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.